サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1279799

子癇前症診断薬の世界市場規模調査＆予測：検査タイプ別（血液検査、尿検査）、製品別（機器、消耗品）、エンドユーザー別（病院、専門クリニック、診断センター、その他）＆地域別分析、2022-2029年

Global Preeclampsia Diagnostics Market Size study & Forecast, by Test Type (Blood Tests, Urine Analysis), by Product (Instruments, Consumables), by End-User (Hospitals, Specialty Clinics, Diagnostic Centers & Others) & Regional Analysis, 2022-2029
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
子癇前症診断薬の世界市場規模調査＆予測：検査タイプ別（血液検査、尿検査）、製品別（機器、消耗品）、エンドユーザー別（病院、専門クリニック、診断センター、その他）＆地域別分析、2022-2029年
出版日: 2023年05月15日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の子癇前症診断薬市場は、2021年に約10億3,000万米ドルと評価され、予測期間2022-2029年には2.2％以上の健全な成長率で成長すると予測されています。

一般に毒素症と呼ばれる子癇前症は、血圧の上昇と妊婦の尿中の高タンパクを特徴とする進行性の病態です。先進国や発展途上国の女性の母体および周産期の罹患率や死亡率を加速させる妊娠高血圧症候群の1つがこれです。子癇前症診断薬市場は、女性人口における子癇前症の発症率の増加や、革新的な子癇前症診断薬の開発への注目の高まりなどの要因から拡大しています。

世界の妊婦は、早期子癇前症診断に対する需要が高まっており、予測期間中、子癇前症診断市場の拡大を促進すると予想されます。例えば、子癇前症財団は、世界で毎年1,000万人以上の女性が子癇前症に苦しんでおり、子癇前症は250万人以上の早産に寄与していると予測しています。さらに、疾病管理予防センターによると、この間、子癇前症は少なくとも7件に1件の分娩に影響を与え、分娩のための入院におけるその有病率は2017年の約13%から2019年には16%に増加しました。スペースの増加を促進するもう一つの重要な要素は、子癇前症の診断と治療に対する助成金の増加です。例えば、2022年2月2日に、子癇前症財団とそのカナダの関連団体である子癇前症財団カナダは、子癇前症および関連する妊娠高血圧症候群の調査のために、それぞれ1つの医学研究ビジョングラント（最高2万米ドルまで）を授与する予定です。しかし、子癇前症に関する認知度が低いことが、市場の成長を妨げる可能性があります。

その他のアジア太平洋地域、北米、欧州、中南米、世界のその他の地域は、「子癇前症診断薬」の世界市場調査において考慮されています。北米は売上高で市場を独占しています。この地域の市場拡大は、技術的に改良された商品の採用が進んでいること、病気の深刻さに対する患者やヘルスケアプロバイダーの意識が高まっていること、そしてかなりの医療費がかかっていることに起因しています。さらに、より最先端の子癇前症診断薬が登場することで、この業界は上昇すると予測されています。一方、欧州は、対象人口の増加などの要因により、予測期間中に最も高いCAGRで成長すると予想されます。さらに、妊娠中に高血圧の問題を抱える患者層が多いことも、市場の成長を促進すると予想されます。また、妊娠高血圧症候群の診断を承認する政府ヘルスケア機関の増加も、欧州での市場拡大を促進する可能性があります。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国の産業の質的・量的な側面を取り入れるよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢と市場情勢の詳細な分析とともに、利害関係者が投資するためのミクロ市場での潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

  • マーケットスナップショット
  • 世界市場・セグメント別市場推計・予測、2019年～2029年
    • 子癇前症診断薬市場、地域別、2019年-2029年
    • 子癇前症診断薬市場：検査タイプ別、2019年-2029年
    • 子癇前症診断薬市場：製品別、2019年-2029年
    • 子癇前症診断薬市場：エンドユーザー別、2019年～2029年
  • 主な動向
  • 予測手法
  • 調査の前提条件

第2章 子癇前症診断薬の世界市場定義と範囲

  • 本調査の目的
  • 市場の定義と範囲
    • 調査対象範囲
    • 産業の進化
  • 調査対象年
  • 通貨換算レート

第3章 世界の子癇前症診断薬市場力学

  • 子癇前症診断薬市場の影響分析（2019年～2029年）
    • 市場促進要因
      • 女性人口における子癇前症の発生率の増加
      • 革新的な子癇前症診断薬の開発への注目の高まり
    • 市場の課題
      • 子癇前症に関する認知度の低さ
    • 市場機会
      • 子癇前症の診断と治療のための資金調達の増加

第4章 世界の子癇前症診断薬市場の産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースモデルの未来的アプローチ（2019年～2029年）
  • PEST分析
    • 政治的
    • 経済的
    • 社会的
    • 技術的
  • 主な投資機会
  • 主要成功戦略
  • 業界専門家別展望
  • アナリストの結論・提言

第5章 リスクアセスメントCOVID-19の影響

  • COVID-19が業界に与える全体的な影響についてのアセスメント
  • COVID-19以前とCOVID-19以後の市場シナリオ

第6章 子癇前症診断薬の世界市場、検査タイプ別

  • 市場スナップショット
  • 子癇前症診断薬の世界市場：検査タイプ別、実績 - ポテンシャル分析
  • 子癇前症診断薬の世界市場、検査タイプ別推定・予測2019～2029年
  • 子癇前症診断薬市場、サブセグメント別分析
    • 血液検査
    • 尿検査

第7章 子癇前症診断薬の世界市場：製品別

  • 市場スナップショット
  • 子癇前症診断薬の世界市場：製品別、実績 - ポテンシャル分析
  • 子癇前症診断薬の世界市場、製品別推定・予測2019～2029年
  • 子癇前症診断薬市場、サブセグメント別分析
    • 機器
    • 消耗品

第8章 子癇前症診断薬の世界市場：エンドユーザー別

  • 市場スナップショット
  • 子癇前症診断薬の世界市場：エンドユーザー別、実績 - ポテンシャル分析
  • 子癇前症診断薬の世界市場、エンドユーザー別推定・予測2019～2029年
  • 子癇前症診断薬市場、サブセグメント別分析
    • 病院
    • 専門クリニック
    • 診断センター
    • その他

第9章 子癇前症診断薬の世界市場：地域別分析

  • 子癇前症診断薬市場、地域別市場スナップショット
  • 北米
    • 米国
      • 検査タイプ別の推定・予測、2019年～2029年
      • 製品別の推定・予測、2019年～2029年
      • エンドユーザー別の推定・予測、2019年～2029年
    • カナダ
  • 欧州の子癇前症診断薬市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋の子癇前症診断薬市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの子癇前症診断薬市場スナップショット
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ地域
  • 世界のその他の地域

第10章 競合情報

  • 主要市場戦略
  • 企業プロファイル
    • F. Hoffmann-La Roche Ltd
      • 主要情報
      • 概要
      • 財務（データの入手が可能な場合のみ）
      • 製品概要
      • 最近の開発状況
    • PerkinElmer Inc.
    • DRG instruments GMBH
    • Thermo Fisher Scientific Inc.
    • Diabetomics, Inc.
    • Metabolomic Diagnostics Ltd.
    • Sera Prognostics
    • Siemens Healthineers AG
    • Danaher Corporation（Beckman Coulter, Inc.）
    • Bio-Rad Laboratories, Inc.

第11章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査の特徴
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Preeclampsia Diagnostics Market, report scope
  • TABLE 2. Global Preeclampsia Diagnostics Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Preeclampsia Diagnostics Market estimates & forecasts by Test Type 2019-2029 (USD Billion)
  • TABLE 4. Global Preeclampsia Diagnostics Market estimates & forecasts by Product 2019-2029 (USD Billion)
  • TABLE 5. Global Preeclampsia Diagnostics Market estimates & forecasts by End-User 2019-2029 (USD Billion)
  • TABLE 6. Global Preeclampsia Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Preeclampsia Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Preeclampsia Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Preeclampsia Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Preeclampsia Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Preeclampsia Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Preeclampsia Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Preeclampsia Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Preeclampsia Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. Global Preeclampsia Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Preeclampsia Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 17. U.S. Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. U.S. Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Preeclampsia Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 20. Canada Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. Canada Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Preeclampsia Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 23. UK Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. UK Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Preeclampsia Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 26. Germany Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. Germany Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Preeclampsia Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 29. France Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. France Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Preeclampsia Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 32. Italy Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Italy Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Preeclampsia Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 35. Spain Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. Spain Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Preeclampsia Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 38. RoE Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. RoE Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Preeclampsia Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 41. China Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. China Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Preeclampsia Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 44. India Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. India Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Preeclampsia Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 47. Japan Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. Japan Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Preeclampsia Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 50. South Korea Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. South Korea Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Preeclampsia Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 53. Australia Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. Australia Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Preeclampsia Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. RoAPAC Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Preeclampsia Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 59. Brazil Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Brazil Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Preeclampsia Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 62. Mexico Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. Mexico Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Preeclampsia Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 65. RoLA Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. RoLA Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Preeclampsia Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 68. Row Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. Row Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Preeclampsia Diagnostics Market
  • TABLE 71. List of primary sources, used in the study of global Preeclampsia Diagnostics Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Preeclampsia Diagnostics Market, research methodology
  • FIG 2. Global Preeclampsia Diagnostics Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Preeclampsia Diagnostics Market, key trends 2021
  • FIG 5. Global Preeclampsia Diagnostics Market, growth prospects 2022-2029
  • FIG 6. Global Preeclampsia Diagnostics Market, porters 5 force model
  • FIG 7. Global Preeclampsia Diagnostics Market, pest analysis
  • FIG 8. Global Preeclampsia Diagnostics Market, value chain analysis
  • FIG 9. Global Preeclampsia Diagnostics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Preeclampsia Diagnostics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Preeclampsia Diagnostics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Preeclampsia Diagnostics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Preeclampsia Diagnostics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Preeclampsia Diagnostics Market, regional snapshot 2019 & 2029
  • FIG 15. North America Preeclampsia Diagnostics Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Preeclampsia Diagnostics Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia Pacific Preeclampsia Diagnostics Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Preeclampsia Diagnostics Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Preeclampsia Diagnostics Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Preeclampsia Diagnostics Market is valued at approximately USD 1.03 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 2.2% over the forecast period 2022-2029. Preeclampsia, commonly referred to as toxaemia, is a progressively growing condition marked by raised blood pressure and high protein in pregnant women's urine. One of the hypertensive disorders of pregnancy that accelerates maternal and perinatal morbidity and mortality rates among women in industrialized and developing countries is this one. The Preeclampsia Diagnostics market is expanding because of factors such as increasing incidence of Preeclampsia among female population, and growing focus on the development of innovative preeclampsia diagnostic products.

Pregnant women globally are likely to have a rising demand for early preeclampsia diagnosis, which is anticipated to fuel the expansion of the global preeclampsia diagnostics market over the forecast period. For instance, the Preeclampsia Foundation predicts that over 10 million women worldwide suffer from preeclampsia each year and that preeclampsia contributes to over 2.5 million preterm births. Furthermore, Preeclampsia affected at least 1 in 7 deliveries during this time, according to the Centers for Disease Control and Prevention, and its prevalence among hospitalisations for childbirth increased from around 13% in 2017 to 16% in 2019. Another important component driving space increase is increase in funding for diagnosis and treatment of Preeclampsia. For instance, on February 2, 2022, the Preeclampsia Foundation and Preeclampsia Foundation Canada, its Canadian affiliate, would each award one medical research Vision Grant, up to US$ 20,000, for the study of preeclampsia and related hypertensive diseases of pregnancy. However, less awareness about preeclampsia may halt market growth.

The key regions considered for the Global Preeclampsia Diagnostics Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue. The market expansion in this region is attributed to the increasing adoption of technologically improved goods, rising patient and healthcare provider awareness of the seriousness of the disease, and considerable healthcare spending. Additionally, the industry is projected to rise as more cutting-edge preeclampsia diagnostics products are introduced. Whereas Europe is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising target populations. Further, a sizable patient base with hypertensive problems during pregnancy is expected to fuel market growth. Additionally, a rise in government healthcare organizations' approvals of the diagnosis of hypertensive problems in pregnancy may promote market expansion in Europe.

Major market players included in this report are:

  • F. Hoffmann-La Roche Ltd
  • PerkinElmer Inc.
  • DRG instruments GMBH
  • Thermo Fisher Scientific Inc.
  • Diabetomics, Inc.
  • Metabolomic Diagnostics Ltd.
  • Sera Prognostics
  • Siemens Healthineers AG
  • Danaher Corporation (Beckman Coulter, Inc.)
  • Bio-Rad Laboratories, Inc.

Recent Developments in the Market:

  • In June 2021, In India, LifeCell Diagnostics introduced a thorough preeclampsia screening programme. The sophisticated screening finds sFLT-1 (soluble FMS-like tyrosine kinase-1), a biomarker that allows for reliable diagnosis even in the third trimester and allows for illness prediction.
  • In July 2019, The Preeclampsia Foundation and Predictive Laboratories, Inc. formed a research partnership. The objective of this collaboration is to create a tailored test for the early identification of risk in disease-affected women.

Global Preeclampsia Diagnostics Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Test Type, Product, End-User, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Test Typeofferings of key players. The detailed segments and sub-segment of the market are explained below.

By Test Type:

  • Blood Tests
  • Urine Analysis

By Product:

  • Instruments
  • Consumables

By End-User:

  • Hospitals
  • Specialty Clinics
  • Diagnostic Centers
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Preeclampsia Diagnostics Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Preeclampsia Diagnostics Market, by Test Type, 2019-2029 (USD Billion)
    • 1.2.3. Preeclampsia Diagnostics Market, by Product, 2019-2029 (USD Billion)
    • 1.2.4. Preeclampsia Diagnostics Market, by End-User, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Preeclampsia Diagnostics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Preeclampsia Diagnostics Market Dynamics

  • 3.1. Preeclampsia Diagnostics Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing incidence of Preeclampsia among female population
      • 3.1.1.2. Growing Focus on the Development of Innovative Preeclampsia Diagnostic Products
    • 3.1.2. Market Challenges
      • 3.1.2.1. Less Awareness about Preeclampsia
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increase in Funding for Diagnosis and Treatment of Preeclampsia

Chapter 4. Global Preeclampsia Diagnostics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Preeclampsia Diagnostics Market, by Test Type

  • 6.1. Market Snapshot
  • 6.2. Global Preeclampsia Diagnostics Market by Test Type, Performance - Potential Analysis
  • 6.3. Global Preeclampsia Diagnostics Market Estimates & Forecasts by Test Type 2019-2029 (USD Billion)
  • 6.4. Preeclampsia Diagnostics Market, Sub Segment Analysis
    • 6.4.1. Blood Tests
    • 6.4.2. Urine Analysis

Chapter 7. Global Preeclampsia Diagnostics Market, by Product

  • 7.1. Market Snapshot
  • 7.2. Global Preeclampsia Diagnostics Market by Product, Performance - Potential Analysis
  • 7.3. Global Preeclampsia Diagnostics Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
  • 7.4. Preeclampsia Diagnostics Market, Sub Segment Analysis
    • 7.4.1. Instruments
    • 7.4.2. Consumables

Chapter 8. Global Preeclampsia Diagnostics Market, by End-User

  • 8.1. Market Snapshot
  • 8.2. Global Preeclampsia Diagnostics Market by End-User, Performance - Potential Analysis
  • 8.3. Global Preeclampsia Diagnostics Market Estimates & Forecasts by End-User 2019-2029 (USD Billion)
  • 8.4. Preeclampsia Diagnostics Market, Sub Segment Analysis
    • 8.4.1. Hospitals
    • 8.4.2. Specialty Clinics
    • 8.4.3. Diagnostic Centers
    • 8.4.4. Others

Chapter 9. Global Preeclampsia Diagnostics Market, Regional Analysis

  • 9.1. Preeclampsia Diagnostics Market, Regional Market Snapshot
  • 9.2. North America Preeclampsia Diagnostics Market
    • 9.2.1. U.S. Preeclampsia Diagnostics Market
      • 9.2.1.1. Test Type breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Product breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. End-User breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Preeclampsia Diagnostics Market
  • 9.3. Europe Preeclampsia Diagnostics Market Snapshot
    • 9.3.1. U.K. Preeclampsia Diagnostics Market
    • 9.3.2. Germany Preeclampsia Diagnostics Market
    • 9.3.3. France Preeclampsia Diagnostics Market
    • 9.3.4. Spain Preeclampsia Diagnostics Market
    • 9.3.5. Italy Preeclampsia Diagnostics Market
    • 9.3.6. Rest of Europe Preeclampsia Diagnostics Market
  • 9.4. Asia-Pacific Preeclampsia Diagnostics Market Snapshot
    • 9.4.1. China Preeclampsia Diagnostics Market
    • 9.4.2. India Preeclampsia Diagnostics Market
    • 9.4.3. Japan Preeclampsia Diagnostics Market
    • 9.4.4. Australia Preeclampsia Diagnostics Market
    • 9.4.5. South Korea Preeclampsia Diagnostics Market
    • 9.4.6. Rest of Asia Pacific Preeclampsia Diagnostics Market
  • 9.5. Latin America Preeclampsia Diagnostics Market Snapshot
    • 9.5.1. Brazil Preeclampsia Diagnostics Market
    • 9.5.2. Mexico Preeclampsia Diagnostics Market
    • 9.5.3. Rest of Latin America Preeclampsia Diagnostics Market
  • 9.6. Rest of The World Preeclampsia Diagnostics Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. F. Hoffmann-La Roche Ltd
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. PerkinElmer Inc.
    • 10.2.3. DRG instruments GMBH
    • 10.2.4. Thermo Fisher Scientific Inc.
    • 10.2.5. Diabetomics, Inc.
    • 10.2.6. Metabolomic Diagnostics Ltd.
    • 10.2.7. Sera Prognostics
    • 10.2.8. Siemens Healthineers AG
    • 10.2.9. Danaher Corporation (Beckman Coulter, Inc.)
    • 10.2.10. Bio-Rad Laboratories, Inc.

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption